Aurothioglucose

A gold-containing glucose derivate.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Aurothioglucose is a drug formerly used for rheumatoid arthritis treatment. It contains a sulfhydryl group and a gold cation, which were hypothesized to inhibit adenylyl cyclase in some lymphocyte populations, leading to inhibition of mast cell degranulation, respiratory burst effect enhancement and other pro-inflammatory processes (DrugBank).

Aurothioglucose on PubChem
Aurothioglucose on Wikipedia



Synonyms

Gold thioglucose


Marketed as

RENOL; ORONOL; ROMOSOL; SOLGANAL; SOLGANAL B

 

Structure image - Aurothioglucose

C([C@@H]1[C@H]([C@@H]([C@H](C(O1)[S-])O)O)O)O.[Au+]


Supporting references

Link Tested on Impact factor Notes Publication date
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
3CLpro Enzyme assay In vitro In silico Screening
in silico; in vitro enzyme assay 2.74

Inhibited the SARS-CoV-2 3C-like protease in vitro with IC50 of ca. 13.32 μM.

Feb/01/2021